ELANE and neoplasm: By the 21st day, the average tumor volume of control xenografts reached to 996.75 ± 84.83 mm3, which was significantly reduced to 583.31 ± 53.76 mm3 (~42%) and 364.78 ± 47.65 (64%) following Myricetin and Myr-NE treatment respectively.